Quick Answer
Lunai Bioworks Inc. reported Stockholders Equity of -$21.35 million for the year ending 2025.
- Lunai Bioworks Inc. showed a decrease of -116.2% in Stockholders Equity from 2024 to 2025.
- This data is from Lunai Bioworks Inc.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2011 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: -$2.35 million | Q2 2014: -$2.63 million | Q3 2014: -$2.38 million | Q4 2014: $3.48 million | Q1 2015: $2.67 million | Q3 2015: $717.0 thousand | Q4 2015: $441.8 thousand | Q1 2016: -$63.4 thousand | Q3 2016: -$798.0 thousand | Q4 2016: -$1.28 million | Q1 2017: -$1.61 million | Q3 2017: $2.76 million | Q4 2017: $1.85 million | Q1 2018: -$143.36 million | Q3 2018: $158.38 million | Q4 2018: $155.40 million | Q1 2019: $152.62 million | Q3 2019: $172.18 million | Q4 2019: $171.28 million | Q1 2020: $170.22 million | Q3 2020: $164.23 million | Q4 2020: $161.94 million | Q1 2021: $162.32 million | Q3 2021: $166.97 million | Q4 2021: $165.62 million | Q1 2022: $161.24 million | Q3 2022: $70.32 million | Q4 2022: $66.90 million | Q1 2023: $66.13 million | Q3 2023: $46.75 million | Q4 2023: $43.60 million | Q1 2024: $168.60 million | Q2 2024: $131.98 million | Q3 2024: $98.09 million | Q4 2024: $82.06 million | Q1 2025: $88.39 million | Q2 2025: -$21.35 million | Q3 2025: -$13.04 million | Q4 2025: -$13.55 million.
- Historical annual values: Fiscal year 2025: -$21.35 million | Fiscal year 2024: $131.98 million | Fiscal year 2023: $46.50 million | Fiscal year 2022: $72.62 million | Fiscal year 2021: $174.66 million | Fiscal year 2020: $166.27 million | Fiscal year 2019: $173.10 million | Fiscal year 2018: $158.74 million | Fiscal year 2017: $1.53 million | Fiscal year 2016: -$637.4 thousand | Fiscal year 2015: $1.08 million | Fiscal year 2014: $3.48 million | Fiscal year 2013: -$1.68 million | Fiscal year 2013: -$51.3 thousand | Fiscal year 2012: -$13.7 thousand | Fiscal year 2011: -$8.7 thousand | Fiscal year 2011: $0.00.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: